111 related articles for article (PubMed ID: 16647240)
21. Behavioral consequences of repeated nicotine during adolescence in alcohol-preferring AA and alcohol-avoiding ANA rats.
Kemppainen H; Hyytiä P; Kiianmaa K
Alcohol Clin Exp Res; 2009 Feb; 33(2):340-9. PubMed ID: 19032573
[TBL] [Abstract][Full Text] [Related]
22. Targeted naltrexone treatment moderates the relations between mood and drinking behavior among problem drinkers.
Kranzler HR; Armeli S; Feinn R; Tennen H
J Consult Clin Psychol; 2004 Apr; 72(2):317-27. PubMed ID: 15065964
[TBL] [Abstract][Full Text] [Related]
23. Naltrexone plus benzodiazepine aids abstinence in opioid-dependent patients.
Stella L; D'Ambra C; Mazzeo F; Capuano A; Del Franco F; Avolio A; Ambrosino F
Life Sci; 2005 Oct; 77(21):2717-22. PubMed ID: 15979652
[TBL] [Abstract][Full Text] [Related]
24. Treating university students with social phobia and public speaking fears: Internet delivered self-help with or without live group exposure sessions.
Tillfors M; Carlbring P; Furmark T; Lewenhaupt S; Spak M; Eriksson A; Westling BE; Andersson G
Depress Anxiety; 2008; 25(8):708-17. PubMed ID: 18729147
[TBL] [Abstract][Full Text] [Related]
25. Mental reinstatement of context and return of fear in spider-fearful participants.
Mystkowski JL; Craske MG; Echiverri AM; Labus JS
Behav Ther; 2006 Mar; 37(1):49-60. PubMed ID: 16942960
[TBL] [Abstract][Full Text] [Related]
26. Comparison of behavioral and cognitive-behavioral one-session exposure treatments for small animal phobias.
Koch EI; Spates CR; Himle JA
Behav Res Ther; 2004 Dec; 42(12):1483-504. PubMed ID: 15500817
[TBL] [Abstract][Full Text] [Related]
27. What role does measuring medication compliance play in evaluating the efficacy of naltrexone?
Baros AM; Latham PK; Moak DH; Voronin K; Anton RF
Alcohol Clin Exp Res; 2007 Apr; 31(4):596-603. PubMed ID: 17374038
[TBL] [Abstract][Full Text] [Related]
28. Behavioral therapy to augment oral naltrexone for opioid dependence: a ceiling on effectiveness?
Nunes EV; Rothenberg JL; Sullivan MA; Carpenter KM; Kleber HD
Am J Drug Alcohol Abuse; 2006; 32(4):503-17. PubMed ID: 17127538
[TBL] [Abstract][Full Text] [Related]
29. Effectiveness of low-dose naltrexone in the post-detoxification treatment of opioid dependence.
Mannelli P; Patkar AA; Peindl K; Murray HW; Wu LT; Hubbard R
J Clin Psychopharmacol; 2007 Oct; 27(5):468-74. PubMed ID: 17873678
[TBL] [Abstract][Full Text] [Related]
30. Naltrexone for the treatment of obesity: review and update.
Lee MW; Fujioka K
Expert Opin Pharmacother; 2009 Aug; 10(11):1841-5. PubMed ID: 19537999
[TBL] [Abstract][Full Text] [Related]
31. Use of narcotic antagonists to modify stereotypic self-licking, self-chewing, and scratching behavior in dogs.
Dodman NH; Shuster L; White SD; Court MH; Parker D; Dixon R
J Am Vet Med Assoc; 1988 Oct; 193(7):815-9. PubMed ID: 3192459
[TBL] [Abstract][Full Text] [Related]
32. Targeted nalmefene with simple medical management in the treatment of heavy drinkers: a randomized double-blind placebo-controlled multicenter study.
Karhuvaara S; Simojoki K; Virta A; Rosberg M; Löyttyniemi E; Nurminen T; Kallio A; Mäkelä R
Alcohol Clin Exp Res; 2007 Jul; 31(7):1179-87. PubMed ID: 17451401
[TBL] [Abstract][Full Text] [Related]
33. Does the form or the amount of exposure make a difference in the cognitive-behavioral therapy treatment of social phobia?
Borgeat F; Stankovic M; Khazaal Y; Rouget BW; Baumann MC; Riquier F; O'Connor K; Jermann F; Zullino D; Bondolfi G
J Nerv Ment Dis; 2009 Jul; 197(7):507-13. PubMed ID: 19597358
[TBL] [Abstract][Full Text] [Related]
34. Psychological approaches in the treatment of specific phobias: a meta-analysis.
Wolitzky-Taylor KB; Horowitz JD; Powers MB; Telch MJ
Clin Psychol Rev; 2008 Jul; 28(6):1021-37. PubMed ID: 18410984
[TBL] [Abstract][Full Text] [Related]
35. Naltrexone effects on male sexual behavior, corticosterone, and testosterone in stressed male rats.
Retana-Márquez S; Bonilla-Jaime H; Vázquez-Palacios G; Martínez-García R
Physiol Behav; 2009 Feb; 96(2):333-42. PubMed ID: 19027764
[TBL] [Abstract][Full Text] [Related]
36. Specific phobias.
Hamm AO
Psychiatr Clin North Am; 2009 Sep; 32(3):577-91. PubMed ID: 19716991
[TBL] [Abstract][Full Text] [Related]
37. The immediate effect of a brief energy psychology intervention (Emotional Freedom Techniques) on specific phobias: a pilot study.
Salas MM; Brooks AJ; Rowe JE
Explore (NY); 2011; 7(3):155-61. PubMed ID: 21571234
[TBL] [Abstract][Full Text] [Related]
38. Naltrexone is associated with reduced drinking by alcohol dependent patients receiving antidepressants for mood and anxiety symptoms: results from VA Cooperative Study No. 425, "Naltrexone in the treatment of alcoholism".
Krystal JH; Gueorguieva R; Cramer J; Collins J; Rosenheck R;
Alcohol Clin Exp Res; 2008 Jan; 32(1):85-91. PubMed ID: 18070245
[TBL] [Abstract][Full Text] [Related]
39. One-session treatment of specific phobias: a detailed description and review of treatment efficacy.
Zlomke K; Davis TE
Behav Ther; 2008 Sep; 39(3):207-23. PubMed ID: 18721635
[TBL] [Abstract][Full Text] [Related]
40. Comparative treatment and mortality correlates and adverse event profile of implant naltrexone and sublingual buprenorphine.
Reece AS
J Subst Abuse Treat; 2009 Oct; 37(3):256-65. PubMed ID: 19394789
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
